We are live on ! Find out more
DFO

Duquesne Family Office Portfolio holdings

AUM $5.21B
1-Year Est. Return 87.01%
This Fund
S&P 500
This Quarter Est. Return
+19.06%
1 Year Est. Return
+87.01%
3 Year Est. Return
+345.18%
5 Year Est. Return
+545.74%
10 Year Est. Return
+5,317.36%
AUM
$2.31B
AUM Growth
+$288M
Cap. Flow
+$82.6M
Cap. Flow %
3.58%
Top 10 Hldgs %
70.78%
Holding
77
New
19
Increased
7
Reduced
10
Closed
29

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$186M
2
IQV icon
IQVIA
IQV
+$101M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$84.2M
4
AMZN icon
Amazon
AMZN
+$78.1M
5
TECK icon
Teck Resources
TECK
+$57.7M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$127M
2
META icon
Meta Platforms (Facebook)
META
+$113M
3
VRT icon
Vertiv
VRT
+$56.9M
4
CVE icon
Cenovus Energy
CVE
+$52.4M
5
LLY icon
Eli Lilly
LLY
+$44.4M

Sector Composition

Rank Sector Weight
1 Technology 25.32%
2 Healthcare 19.23%
3 Consumer Discretionary 18.06%
4 Communication Services 11.8%
5 Consumer Staples 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWS icon
26
News Corp Class B
NWS
$17.9B
$10.7M 0.46%
+613,050
New +$11.3M
PSX icon
27
Phillips 66
PSX
$106B
$10.2M 0.44%
100,555
-13,295
-12% -$1.35M
WSC icon
28
WillScot Mobile Mini Holdings
WSC
$3.27B
$10.1M 0.44%
215,500
-94,366
-30% -$4.54M
ARCH
29
DELISTED
Arch Resources, Inc.
ARCH
$9.95M 0.43%
75,665
-53,475
-41% -$7.74M
ISEE
30
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$9.73M 0.42%
+400,000
New +$8.76M
RXRX icon
31
Recursion Pharmaceuticals
RXRX
$1.71B
$9.26M 0.4%
1,385,950
HUBS icon
32
HubSpot
HUBS
$11.8B
$8.7M 0.38%
+20,300
New +$7.41M
WRBY icon
33
Warby Parker
WRBY
$2.91B
$6.85M 0.3%
+646,500
New +$8.86M
PLTR icon
34
Palantir
PLTR
$419B
$5.92M 0.26%
700,707
-570,000
-45% -$4.46M
TOST icon
35
Toast
TOST
$18B
$5.82M 0.25%
+327,700
New +$6.46M
FXI icon
36
iShares China Large-Cap ETF
FXI
$4.04B
$5.42M 0.23%
+183,410
New +$5.51M
IHS icon
37
IHS Holding
IHS
$2.85B
$5.4M 0.23%
771,096
ANET icon
38
Arista Networks
ANET
$249B
$5.37M 0.23%
+128,000
New +$4.4M
BABA icon
39
Alibaba
BABA
$267B
$5.2M 0.23%
+50,915
New +$5.1M
ABCL icon
40
AbCellera Biologics
ABCL
$3.78B
$4.97M 0.22%
659,750
BNTX icon
41
BioNTech
BNTX
$24.1B
$4.83M 0.21%
+38,800
New +$5.33M
MRNA icon
42
Moderna
MRNA
$58.1B
$3.4M 0.15%
22,154
OPEN icon
43
Opendoor
OPEN
$2.52B
$2.71M 0.12%
1,589,355
CCC
44
CCC Intelligent Solutions
CCC
$3.73B
$2.53M 0.11%
281,879
ACAD icon
45
Acadia Pharmaceuticals
ACAD
$4.75B
$1.4M 0.06%
74,400
COMP icon
46
Compass
COMP
$7.93B
$1.29M 0.06%
399,100
FTH
47
Faeth Therapeutics
FTH
$885M
$150K 0.01%
5,000
JOBY icon
48
Joby Aviation
JOBY
$6.04B
$38K ﹤0.01%
11,246
ALNY icon
49
Alnylam Pharmaceuticals
ALNY
$32B
-88,910
Closed -$21.1M
AMR icon
50
Alpha Metallurgical Resources
AMR
$2.4B
-39,370
Closed -$5.76M

Similar funds

Duquesne Family Office's Q1 2023 Portfolio in Review

As of Q1 2023, Duquesne Family Office held 77 positions worth $2.31B, up 14% from $2.02B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Duquesne Family Office deployed $82.6M of net new capital in Q1 2023, opening 19 new positions and adding to 7 existing holdings. Its largest new stake was Microsoft: 729,040 shares worth $210M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 8.5% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Chevron, an estimated $127M trimmed.

  • Duquesne Family Office's largest Q1 2023 buy was Microsoft: 729,040 shares worth $210M.
  • Duquesne Family Office added most to Teck Resources in Q1 2023, an estimated $57.7M increase.
  • Duquesne Family Office's biggest Q1 2023 reduction was Chevron, cutting an estimated $127M.
  • Duquesne Family Office fully exited Cenovus Energy in Q1 2023, selling an estimated $52.4M.
  • Duquesne Family Office's ten largest holdings make up 71% of its $2.31B portfolio in Q1 2023.
  • Duquesne Family Office opened 19 new positions and closed 29 in Q1 2023.
  • Duquesne Family Office's portfolio value rose 14% quarter-over-quarter to $2.31B.

Based on Duquesne Family Office's 13F filing for Q1 2023, filed 15 May 2023.